Peer-reviewed veterinary case report
Dog with chemotherapy vein inflammation after cancer treatment
By Seoyoung Hwang et al.·Published in Frontiers in Veterinary Science·2025·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Case Report: Chemotherapy-induced phlebitis in a dog: diagnostic approach and management strategies
- Species:
- dog
Plain-English summary
A 7-year-old neutered male Golden Retriever with osteosarcoma (bone cancer) had his left leg amputated and started chemotherapy. After receiving a chemotherapy drug called doxorubicin, he developed heat, swelling, pain, and limping in his right front leg due to phlebitis (inflammation of a vein). The vet confirmed this with an ultrasound and treated him with anti-inflammatory medications, oral drugs, and low-level laser therapy. Although he improved, phlebitis occurred in other veins, but he continued to respond well to treatment. After completing chemotherapy, he remained stable for over 13 months without any signs of cancer returning.
People also search for: dog chemotherapy side effects · Golden Retriever phlebitis treatment · doxorubicin complications in dogs
Abstract
A 7-year-old neutered male Golden Retriever diagnosed with osteosarcoma of the left radius underwent limb amputation followed by adjuvant chemotherapy utilizing alternating carboplatin-doxorubicin protocols. Following doxorubicin administration, the patient exhibited localized heat, swelling, pain, and lameness in the right forelimb, indicative of phlebitis. Ultrasonography confirmed chemotherapy-induced phlebitis with thickening of the right cephalic vein wall, intraluminal thrombi, and significant perivascular edema. Treatment involved anti-inflammatory corticosteroids, oral medications (clopidogrel, pentoxifylline, doxycycline, vitamin E), and low-level laser therapy (LLLT), achieving clinical improvement. Despite successful control of chronic inflammation in the cephalic vein, phlebitis subsequently developed in other veins, including the right common dorsal digital vein and left saphenous vein, despite varying vascular access points. The patient showed clinical improvement with the combined use of oral medication and low-level laser therapy. The chemotherapy regimen was completed successfully without osteosarcoma recurrence, and the patient remained stable for over 13 months post-treatment. Following discontinuation of chemotherapy and supportive care, no further progression of phlebitis occurred. To the authors' knowledge, this report represents the first documented veterinary case of chemotherapy-induced phlebitis in a dog. While extensively reported in human oncology, chemotherapy-induced phlebitis remains underreported in veterinary medicine. Clinicians should recognize phlebitis as a potential complication associated with chemotherapeutic agents such as doxorubicin and carboplatin. Ultrasonography serves as an essential diagnostic and monitoring tool. Prophylactic corticosteroids and adjunctive low-level laser therapy offer promising preventative and therapeutic strategies, particularly for patients with predisposed vascular inflammation. This case underscores the importance of early identification, proactive management, and individualized treatment approaches to chemotherapy-associated phlebitis in veterinary oncology.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.3389/fvets.2025.1628931